HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths

Research output: Contribution to journalLetterOther

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)479 - 479
Number of pages1
JournalMedical Journal of Australia
Volume202
Issue number9
DOIs
Publication statusPublished - 2015

Cite this

@article{a4bcdbb46084432a8d8638b97ce103c4,
title = "HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths",
author = "William Sievert",
year = "2015",
doi = "10.5694/mja15.00165",
language = "English",
volume = "202",
pages = "479 -- 479",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "AMPCo",
number = "9",

}

HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths. / Sievert, William.

In: Medical Journal of Australia, Vol. 202, No. 9, 2015, p. 479 - 479.

Research output: Contribution to journalLetterOther

TY - JOUR

T1 - HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths

AU - Sievert, William

PY - 2015

Y1 - 2015

UR - https://www.mja.com.au/system/files/issues/202_09/letters_180515.pdf

U2 - 10.5694/mja15.00165

DO - 10.5694/mja15.00165

M3 - Letter

VL - 202

SP - 479

EP - 479

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 9

ER -